Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ABO 101 - Arbor Biotechnologies

Next Previous
Drug Profile

ABO 101 - Arbor Biotechnologies

Alternative Names: ABO-101 - Arbor Biotechnologies

Latest Information Update: 09 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Arbor Biotechnologies
  • Class Gene therapies
  • Mechanism of Action Glycolate oxidase expression modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Primary hyperoxaluria type 1
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Primary hyperoxaluria type 1

Most Recent Events

  • 06 Oct 2025 Chiesi Farmaceutici and Arbor Biotechnologies enters into an exclusive global collaboration and license agreement for ABO 101 for the treatment of Primary Hyperoxaluria Type 1 (PH1)
  • 16 Jun 2025 Phase-I/II clinical trials in Primary hyperoxaluria type 1 (In adolescents, In children, In adults) in France (IV) (NCT06839235)
  • 13 May 2025 Preclinical trials in Primary hyperoxaluria type 1 in United Kingdom (IV) before May 2025

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top